This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Peyvandi F, Mannucci PM, Lak M, et al. Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients. Br J Haematol 1998; 102: 626-628. doi: 10.1046/j.1365-2141.1998.00806.x.PeyvandiFMannucciPMLakM.Congenital factor X deficiency: spectrum of bleeding symptoms in 32 Iranian patients.1998;102:626-628. doi:10.1046/j.1365-2141.1998.00806.x.Open DOISearch in Google Scholar
Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood 2015; 125: 2052-2061. doi: 10.1182/blood-2014-08-532820.PallaRPeyvandiFShapiroAD.Rare bleeding disorders: diagnosis and treatment.2015;125:2052-2061. doi:10.1182/blood-2014-08-532820.Open DOISearch in Google Scholar
Al-Mouqdad M, Abdelrahim A, Kahlon BMM, Almahmoud L, Asfour S. A successful treatment of infant who had two significant intracranial hemorrhage with factor X replacement: case report. Neonat Pediatr Med 2018; 4: 163. doi: 10.4172/2572-4983.1000163.Al-MouqdadMAbdelrahimAKahlonBMMAlmahmoudLAsfourS.A successful treatment of infant who had two significant intracranial hemorrhage with factor X replacement: case report.2018;4:163. doi:10.4172/2572-4983.1000163.Open DOISearch in Google Scholar
Escobar MA. Advances in the treatment of inherited coagulation disorders. Haemophilia 2013; 19: 648-659. doi: 10.1111/hae.12137.EscobarMA.Advances in the treatment of inherited coagulation disorders.2013;19:648-659. doi:10.1111/hae.12137.Open DOISearch in Google Scholar
Menegatti M, Peyvandi F. Factor X deficiency. Semin Thromb Hemost 2009; 35: 407-415. doi: 10.1055/s-0029-1225763.MenegattiMPeyvandiF.Factor X deficiency.2009;35:407-415. doi:10.1055/s-0029-1225763.Open DOISearch in Google Scholar
Powell JS, Rodgers GM. Inherited coagulation disorders. In: Greer JP, Arber DA, Glader B, et al. (eds.). Wintrobe’s Clinical Hematology. 13th edn. 2014. Philadelphia: Lippincott Williams & Wilkins.1143-1185.PowellJSRodgersGM.Inherited coagulation disorders. In:GreerJPArberDAGladerB. (eds.)..13th edn.2014.Philadelphia:Lippincott Williams & Wilkins.1143-1185.Search in Google Scholar
World Federation of Hemophilia. Report on the Annual Global Survey 2021. October 2022. Available from https://www1.wfh.org/publications/files/pdf-2324.pdf (accessed 10 June 2023).World Federation of Hemophilia..October2022. Available from https://www1.wfh.org/publications/files/pdf-2324.pdf(accessed 10 June 2023).Search in Google Scholar
Shah NM, Patel AP. An analysis of 8 cases of factor X deficiency. Indian J Hematol Blood Transfus 2008; 24 (1): 23-25. doi: 10.1007/s12288-008-0018-7.ShahNMPatelAP.An analysis of 8 cases of factor X deficiency.2008;24(1):23-25. doi:10.1007/s12288-008-0018-7.Open DOISearch in Google Scholar
Sinha S, Barik S. Factor X deficiency: a rare case of inherited coagulation disorder presenting as hemarthrosis. Int J Med Res Rev 2014; 2(3): 253-255. doi:10.17511/ijmrr.2014.i03.14.SinhaSBarikS.Factor X deficiency: a rare case of inherited coagulation disorder presenting as hemarthrosis.2014;2(3):253-255. doi:10.17511/ijmrr.2014.i03.14.Open DOISearch in Google Scholar
Chatterjee T, Philip J, Nair V, et al. Inherited factor X (Stuart-Prower factor) deficiency and its management. Med J Armed Forces India 2015; 71 (suppl 1): S184-S186. doi: 10.1016/j. mjafi.2014.01.007.ChatterjeeTPhilipJNairV.Inherited factor X (Stuart-Prower factor) deficiency and its management.2015;71(suppl 1):S184-S186. doi:10.1016/j. mjafi.2014.01.007.Open DOISearch in Google Scholar
Peyvandi F, Auerswald G, Austin SK, et al. Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency. Blood Rev 2021; 50: 100833. doi: 10.1016/j.blre.2021.100833.PeyvandiFAuerswaldGAustinSK.Diagnosis, therapeutic advances, and key recommendations for the management of factor X deficiency.2021;50:100833. doi:10.1016/j.blre.2021.100833.Open DOISearch in Google Scholar
Mumford AD, Ackroyd S, Alikhan R, et al. Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for Standards in Haematology. Br J Haematol 2014; 167: 304-26. doi: 10.1111/bjh.13058.MumfordADAckroydSAlikhanR.Guideline for the diagnosis and management of the rare coagulation disorders: a United Kingdom Haemophilia Centre Doctors’ Organization guideline on behalf of the British Committee for Standards in Haematology.2014;167:304-26. doi:10.1111/bjh.13058.Open DOISearch in Google Scholar
Turecek PL, Váradi K, Gritsch H, Schwarz HP. FEIBA: mode of action. Haemophilia 2004; 10 Suppl 2: 3-9. doi: 10.1111/j.1365-2516.2004.00934.x.TurecekPLVáradiKGritschHSchwarzHP.FEIBA: mode of action.2004;10Suppl 2:3-9. doi:10.1111/j.1365-2516.2004.00934.x.Open DOISearch in Google Scholar
Bolton-Maggs PH, Perry DJ, Chalmers EA, et al. The rare coagulation disorders—review with guidelines for management from the United Kingdom Haemophilia Centre Doctors’ Organisation. Haemophilia 2004; 10: 593-628. doi: 10.1111/j.1365-2516.2004.00944.x.Bolton-MaggsPHPerryDJChalmersEA.The rare coagulation disorders—review with guidelines for management from the United Kingdom Haemophilia Centre Doctors’ Organisation.2004;10:593-628. doi:10.1111/j.1365-2516.2004.00944.x.Open DOISearch in Google Scholar
Peyvandi F, Palla R, Menegatti M, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders. J Thromb Haemost 2012; 10: 615-21. doi: 10.1111/j.1538-7836.2012.04653.x.PeyvandiFPallaRMenegattiM.Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European Network of Rare Bleeding Disorders.2012;10:615-21. doi:10.1111/j.1538-7836.2012.04653.x.Open DOISearch in Google Scholar
Peyvandi F, Di Michele D, Bolton-Maggs PH, et al. Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity. J Thromb Haemost 2012; 10: 1938-43. doi: 10.1111/j.1538-7836.2012.04844.x.PeyvandiFDi MicheleDBolton-MaggsPH.Classification of rare bleeding disorders (RBDs) based on the association between coagulant factor activity and clinical bleeding severity.2012;10:1938-43. doi:10.1111/j.1538-7836.2012.04844.x.Open DOISearch in Google Scholar
Shinohara K, Adachi M, Matsui K, et al. A case of factor X (FX) deficiency due to novel mutation V196M, FX Hofu. Int J Hematol 2008; 87(3): 256-259. doi: 10.1007/s12185-008-0035-1.ShinoharaKAdachiMMatsuiK.A case of factor X (FX) deficiency due to novel mutation V196M, FX Hofu.2008;87(3):256-259. doi:10.1007/s12185-008-0035-1.Open DOISearch in Google Scholar
Peyvandi F, Menegatti M, Santagostino E, et al. Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency. Br J Haematol 2002; 117: 685-692. doi: 10.1046/j.1365-2141.2002.03486.x.PeyvandiFMenegattiMSantagostinoE.Gene mutations and three-dimensional structural analysis in 13 families with severe factor X deficiency.2002;117:685-692. doi:10.1046/j.1365-2141.2002.03486.x.Open DOISearch in Google Scholar
Telfer TP, Denson KW, Wright DR. A ‘new’ coagulation defect. Br J Haematol 1956; 2(3): 308-316. doi: 10.1111/j.1365-2141-1956.tb06703.x.TelferTPDensonKWWrightDR.A ‘new’ coagulation defect.1956;2(3):308-316. doi:10.1111/j.1365-2141-1956.tb06703.x.Open DOISearch in Google Scholar
Hougie C, Barrow EM, Graham JB. Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency. J Clin Invest 1957; 36: 485-496. doi: 10.1172/JCI103446.HougieCBarrowEMGrahamJB.Stuart clotting defect. I. Segregation of an hereditary hemorrhagic state from the heterogeneous group heretofore called stable factor (SPCA, proconvertin, factor VII) deficiency.1957;36:485-496. doi:10.1172/JCI103446.Open DOISearch in Google Scholar
Redely SV, Zhou ZQ, Rao KJ, Scott JP, Watzke H, High KA, Jagadeeswaran P. Molecular characterization of human factor XSan.Antonio. Blood 1989; 74(5): 1486-90. doi: 10.1182/blood. V74.5.1486.1486.RedelySVZhouZQRaoKJScottJPWatzkeHHighKAJagadeeswaranP.Molecular characterization of human factor XSan.Antonio.1989;74(5):1486-90. doi:10.1182/blood. V74.5.1486.1486.Open DOISearch in Google Scholar
James HL, Girolami A, Fair DS. Molecular defect in coagulation factor XFriuli results from a substitution of serine for proline at position 343. Blood 1991; 77: 317-323. doi: 10.1182/blood.V77.2.317.317.JamesHLGirolamiAFairDS.Molecular defect in coagulation factor XFriuli results from a substitution of serine for proline at position 343.1991;77:317-323. doi:10.1182/blood.V77.2.317.317.Open DOISearch in Google Scholar
Ermis B, Ors R, Tastekin A, Orhan F. Severe congenital factor X deficiency with intracranial bleeding in two siblings. Brain Dev 2004; 6: 137-138. doi: 10.1016/S0387-7604(03)00119-0.ErmisBOrsRTastekinAOrhanF.Severe congenital factor X deficiency with intracranial bleeding in two siblings.2004;6:137-138. doi:10.1016/S0387-7604(03)00119-0.Open DOISearch in Google Scholar
Sandler E, Gross S. Prevention of recurrent intracranial hemorrhage in a factor X-deficient infant. Am J Pediatr Hematol Oncol 1992; 14: 163-165. doi: 10.1097/00043426-199205000-00012.SandlerEGrossS.Prevention of recurrent intracranial hemorrhage in a factor X-deficient infant.1992;14:163-165. doi:10.1097/00043426-199205000-00012.Open DOISearch in Google Scholar
el Kalla S, Menon NS. Neonatal congenital factor X deficiency. Pediatr Hematol Oncol 1991; 8: 347-354. doi: 10.3109/08880019109028808.el KallaSMenonNS.Neonatal congenital factor X deficiency.1991;8:347-354. doi:10.3109/08880019109028808.Open DOISearch in Google Scholar
Shim YJ, Won DI. Pharmacokinetics and prophylactic use of FEIBA ® in a child with severe congenital factor X deficiency and recurrent spontaneous intracranial haemorrhage: a case report. Haemophilia 2013; 19(6): e364–7. doi: 10.1111/hae.12245.ShimYJWonDI.Pharmacokinetics and prophylactic use of FEIBA ® in a child with severe congenital factor X deficiency and recurrent spontaneous intracranial haemorrhage: a case report.2013;19(6):e364–7. doi:10.1111/hae.12245.Open DOISearch in Google Scholar